Vitreoretinal research update
Dr Will Cunningham reviews three studies on vitreoretinal research.
Dr Will Cunningham4 min read
Advertisement
Dr Will Cunningham reviews three studies on vitreoretinal research.
Incidence and severity of asymptomatic ocular injury in adult and paediatric orbital fractures
Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration Hannah Khan Clinical Ophthalmology, 2023 Review: This review evaluated the current status of
Evan Brown reviews the latest visual function and anomalies research.
Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: a randomised clinical trialLee S S-Y PhD, Lingham G et alClinical and Experimental Ophthalmology
Dr Riyaz Bhikoo reviews the latest in retinal research and uveal melanoma
Drs Leo Sheck and Aaron Yap review the latest research on geographic atrophy and diabetic retinopathy
The risk of uveitis due to prostaglandin analogues in paediatric glaucoma
Geographic atrophy (GA) is the late manifestation of non-neovascular age-related macular degeneration (AMD) characterised by progressive loss of retinal pigment epithelium (RPE) and photoreceptors. Until now, it was a slowly progressive untreatable disease that led to vision loss.
Archway randomised phase 3 trial of ranibizumab port delivery system for nAMDHolekamp N et alOphthalmology, 2022. 129(3): p. 295-307
Telemedicine in oculoplastic and adnexal surgery: clinicians’ perspectives in the UK